Related Content
April 27, 2010 โ A popular statin gained a new indication today in the European Union for prevention of major ...
April 27, 2010
February 23, 2010 โ Experts in anti-platelet therapy will offer their insights and interpretations on emerging agents in ...
February 23, 2010February 9, 2010 โ The FDA approved CRESTOR (rosuvastatin calcium) to reduce the risk of stroke, myocardial infarction ...
February 09, 2010December 17, 2009 โ The University of Virginia (UVa) in Charlottesville and AstraZeneca this week entered into a ...
December 16, 2009December 16, 2009 โ The FDA's Endocrinologic and Metabolic Drugs Advisory Committee yesterday agreed AstraZeneca ...
December 16, 2009December 14, 2009 โ A new drug application (NDA) was recently submitted to the U.S. Food and Drug Administration (FDA) ...
December 14, 2009October 16, 2009 โ AstraZeneca yesterday said the U.S. Food and Drug Administration cleared CRESTOR (rosuvastatin ...
October 16, 2009September 28, 2009 โ New data from the phase III PLATO study showed that ticagrelor (BRILINTA) provided 16 percent ...
September 29, 2009September 2, 2009 โ A new analysis from the JUPITER study showed CRESTOR (rosuvastatin calcium) 20 mg reduced the ...
September 02, 2009
September 1, 2009 โ AstraZeneca last week announced results from the phase III head to head trial, PLATO (A Study of ...
September 01, 2009ยฉ Copyright Wainscot Media. All Rights Reserved.
Subscribe Now